In gastric cancer, NOX2 has been found to be highly expressed in tumor tissues [13], and the NOX2-ROS axis can mediate the activation of tumorigenesis-associated pathways, including the Akt-mTOR, Stat3, and NF-κB signaling pathways [14]. The gene discussed is MTOR; the disease is gastric cancer.